Basic Information
| LncRNA/CircRNA Name | lncCAMTA1 |
| Synonyms | NA |
| Region | GRCh38_1:6785324-7769706 |
| Ensemble | ENSG00000237436 |
| Refseq | NR_149049 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR, Western blot, Luciferase Reporter Assays |
| Sample | cell line (MDA-MB-231) |
| Expression Pattern | differential expression |
| Function Description | Our findings suggested that LncCAMTA1 might promote proliferation and mobility of human breast cancer cell via binding with miR-20b. And VEGF was directly target of miR-20b and regulated activation of MAPK/ERK and JAK/STAT3 signal pathways. |
| Pubmed ID | 28550685 |
| Year | 2017 |
| Title | Long Noncoding RNA CAMTA1 Promotes Proliferation and Mobility of Human Breast Cancer Cell Line MDA- MB-231 Via Targeting miR-20b |
External Links
| Links for lncCAMTA1 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |